MedPath

Northwestern University Human Resources

Northwestern University Human Resources logo
🇺🇸United States
Ownership
Private
Established
1851-01-28
Employees
5K
Market Cap
-
Website
https://www.venturecat.northwestern.edu

Clinical Trials

1.3k

Active:89
Completed:771

Trial Phases

6 Phases

Early Phase 1:44
Phase 1:109
Phase 2:185
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1111 trials with phase data)• Click on a phase to view related trials

Not Applicable
644 (58.0%)
Phase 2
185 (16.7%)
Phase 1
109 (9.8%)
Phase 4
89 (8.0%)
Early Phase 1
44 (4.0%)
Phase 3
40 (3.6%)

REmote Physical ACtivity Intervention for High Blood Pressure Postpartum

Not Applicable
Not yet recruiting
Conditions
Hypertension (HTN)
Hypertension ,Pregnancy
Physical Activity
First Posted Date
2025-08-17
Last Posted Date
2025-08-17
Lead Sponsor
Northwestern University
Target Recruit Count
60
Registration Number
NCT07127731

Pediatricians Building Resilience Through Early Identification for Toddler Well-Being

Not Applicable
Not yet recruiting
Conditions
Mental Health
First Posted Date
2025-07-29
Last Posted Date
2025-07-29
Lead Sponsor
Northwestern University
Target Recruit Count
432
Registration Number
NCT07091240
Locations
🇺🇸

Nemours Children's Health, Wilmington, Delaware, United States

ECP-DL Cell Infusion for Induction in Living Donor Kidney (LDK) Transplants

Not Applicable
Not yet recruiting
Conditions
Kidney Transplant Failure and Rejection
Kidney Transplant; Complications
First Posted Date
2025-07-24
Last Posted Date
2025-07-24
Lead Sponsor
Northwestern University
Target Recruit Count
24
Registration Number
NCT07083830

Characterization of Human Olfactory Amygdala Subregions exp2

Not Applicable
Recruiting
Conditions
Changes in Olfactory Behavior Across Different Contexts Associated With Different Amygdala Subregions
First Posted Date
2025-07-20
Last Posted Date
2025-07-20
Lead Sponsor
Northwestern University
Target Recruit Count
40
Registration Number
NCT07074574
Locations
🇺🇸

Northwestern human olfaction lab, Chicago, Illinois, United States

Comparing Efficiency and Stone-Free Rates Mini PCNL vs Flex URS

Not Applicable
Not yet recruiting
Conditions
Kidney Stones
Nephrolithiasis
Urolithiasis
First Posted Date
2025-07-18
Last Posted Date
2025-07-18
Lead Sponsor
Northwestern University
Target Recruit Count
80
Registration Number
NCT07072598
Locations
🇺🇸

Northwestern Memorial Hospital, Chicago, Illinois, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 269
  • Next

News

FDA-Approved Asthma Drug Zileuton Shows Promise in Preventing Food Allergy Reactions

Northwestern Medicine researchers discovered that Zileuton, an FDA-approved asthma drug, nearly eliminated life-threatening allergic reactions in mice by blocking a previously unknown pathway involving the DPEP1 gene.

Nature Study Validates LIXTE's PP2A Inhibitor LB-100 for Enhanced Cancer Immunotherapy

A Nature study led by MD Anderson researchers found that ovarian cancer patients with PPP2R1A mutations had significantly better overall survival when treated with immune checkpoint blockade therapy.

Prometheus Laboratories Expands Precision-Guided Dosing Platform with New Tests for IBD Biologics

Prometheus Laboratories launched PredictrPK VDZ and PredictrPK UST, precision-guided dosing tests for vedolizumab and ustekinumab in IBD patients, expanding their platform to cover four major biologics.

TRUST Trial Shows Primary Surgery Improves Progression-Free Survival in Advanced Ovarian Cancer Despite Missing Overall Survival Endpoint

The TRUST trial, the first phase III randomized study comparing surgical timing in advanced ovarian cancer, demonstrated statistically significant improvement in progression-free survival with primary cytoreductive surgery versus interval surgery (22.1 vs 19.7 months, HR=0.80, P=.018).

FDA Expands MenQuadfi Meningococcal Vaccine Approval to Include Infants as Young as 6 Weeks

The FDA approved an expanded indication for Sanofi's MenQuadfi meningococcal vaccine to include children aged 6 weeks to 23 months, making it the only MenACWY vaccine with no upper age limit.

Breakthrough Wireless Device Enables Remote Activation of Light-Sensitive Drugs for Pain Management

Scientists have developed the first wireless device capable of remotely activating photoactivable drugs, demonstrating effective pain management using photolabile morphine without typical opioid side effects.

Pneumonia Antibiotic Piperacillin Shows Promise as Targeted Lyme Disease Treatment at 100-Fold Lower Doses

Northwestern University researchers screened nearly 500 FDA-approved compounds and identified piperacillin as a potentially more effective Lyme disease treatment than current standard doxycycline therapy.

Grove Biopharma Secures $30M Funding, Expands to New R&D Facility in Chicago's Fulton Market

Grove Biopharma, a Northwestern University spinout developing therapies for intracellular disease targets, has secured $30 million in Series A financing to fuel its expansion and research initiatives.

ALS Drug NU-9 Shows Promising Results for Alzheimer's Disease in Animal Study

Northwestern University researchers found that NU-9, an experimental drug approved for ALS clinical trials, effectively reduces toxic protein buildup in Alzheimer's disease animal models.

Sibel Health Secures $30 Million Series C Funding and New FDA Clearance for Interoperable Monitoring Platform

Sibel Health has closed a $30 million Series C financing round led by the Steele Foundation for Hope with significant participation from Dräger, positioning the company for commercial expansion.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.